Page last updated: 2024-10-22

albendazole and Meningococcal Infections

albendazole has been researched along with Meningococcal Infections in 1 studies

Meningococcal Infections: Infections with bacteria of the species NEISSERIA MENINGITIDIS.

Research Excerpts

ExcerptRelevanceReference
"A single-dose treatment with albendazole prior to immunization had no effect on meningococcal or cholera vaccine immunogenicity in our study population."5.22A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children. ( Adegnika, AA; Agnandji, ST; Bache, E; Berberich, S; Brückner, S; Elias, J; Esen, M; Fernandes, J; Hass, J; Kremsner, P; Lell, B; Loembe, MM; Mordmüller, B, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brückner, S1
Agnandji, ST1
Elias, J1
Berberich, S1
Bache, E1
Fernandes, J1
Loembe, MM1
Hass, J1
Lell, B1
Mordmüller, B1
Adegnika, AA1
Kremsner, P1
Esen, M1

Trials

1 trial available for albendazole and Meningococcal Infections

ArticleYear
A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
    Vaccine, 2016, 10-17, Volume: 34, Issue:44

    Topics: Albendazole; Animals; Anthelmintics; Antibodies, Bacterial; B-Lymphocytes; Child; Cholera; Cholera V

2016